Wird geladen...
Current Clinical Trials in Non-Muscle Invasive Bladder Cancer (NIMBC)
BACKGROUND: The treatment options for non-muscle invasive bladder cancer (NMIBC) remain limited. BCG was the last major breakthrough in bladder cancer therapy almost 4 decades ago. There have been improvements in the understanding of immune therapies and cancer biology, leading to the development of...
Gespeichert in:
| Veröffentlicht in: | Urol Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556973/ https://ncbi.nlm.nih.gov/pubmed/28778250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2017.06.043 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|